Becton, Dickinson & Co., Babson Diagnostics Announce Strategic Partnership Agreement to Enable Small-Volume Blood Collection for Diagnostic Testing in Retail Settings
February 13, 2020
February 13, 2020
FRANKLIN LAKES, New Jersey, Feb. 13 -- Becton, Dickinson and Co., a medical technology company, issued the following news release:
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company and Babson Diagnostics, a transformative diagnostic blood testing company, announced a long-term strategic partnership agreement to bring laboratory-quality, small-volume blood collection to retail pharmacies.
The partnership reflects emerging health . . .
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company and Babson Diagnostics, a transformative diagnostic blood testing company, announced a long-term strategic partnership agreement to bring laboratory-quality, small-volume blood collection to retail pharmacies.
The partnership reflects emerging health . . .